VIDAS SARS-COV-2 Diagnostic Test Recalled for Substrate Error
bioMerieux is recalling two lots of VIDAS SARS-COV-2 IgG diagnostic tests due to substrate errors that prevent test execution, requiring users to repeat testing and potentially delaying results.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: FDA Class II diagnostic device with substrate errors that prevent test execution. No reported illnesses, injuries, or deaths. Score 3 (High) applies as a risk-of-harm product where injury has not been reported; diagnostic test malfunction poses risk of delayed or missed diagnosis.
Plain-English summary
bioMerieux, Inc. is recalling two lots of VIDAS SARS-COV-2 IgG diagnostic tests (Lot numbers 1008671430 and 1008763910). This in vitro diagnostic device detects IgG antibodies to SARS-COV-2 and was distributed nationwide throughout the United States.
The product has been found to have substrate errors that prevent the test from being executed. When this error occurs, users cannot obtain results from the affected sample and must run another test, potentially delaying diagnosis.
bioMerieux has been receiving an increasing number of complaints related to this substrate error. Users with affected lots should be aware of this issue and monitor for substrate errors during testing.
The recalled product
- Product
- VIDAS SARS-COV-2 IgG, Ref 423834-01
- Manufacturer
- bioMerieux, Inc.
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (3)
- UDI 03573026620745
- Lot #: 1008671430
- 1008763910
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 16 recalled by bioMerieux, Inc. under a single FDA (Devices) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 16 products in this recall →Related recalls
Same manufacturer · bioMerieux, Inc.
See all →- HighVITEK 2 AST-N447 Test Kit Potentially Returns False Resistant Results
FDA (Devices) · 2026-07-15
- HighSusceptibility test cards recalled over false resistant antibiotic results
FDA (Devices) · 2026-02-11
- HighAntimicrobial susceptibility test cards recalled over false colistin resistance results
FDA (Devices) · 2025-10-08
- SevereVITEK 2 AST Test Kits: Ceftriaxone Concentration Error Risk
FDA (Devices) · 2024-05-01
- HighMedical Device Middleware: MYLA Software Fails to Apply AST Filter Rules
FDA (Devices) · 2023-03-08
Same hazard · substrate error
See all →- ModerateFDA Recalls VIDAS PRG Progesterone Test Kits for Substrate Error
FDA (Devices) · 2022-01-05
- ModerateDiagnostic substrate error in medical testing device causes test failures
FDA (Devices) · 2022-01-05
- HighVIDAS procalcitonin diagnostic test substrate error causes testing delays
FDA (Devices) · 2022-01-05
- HighVIDAS Mumps IgG diagnostic test kit recalled due to substrate error
FDA (Devices) · 2022-01-05
- ModerateVIDAS LH diagnostic test substrate error causes delayed results
FDA (Devices) · 2022-01-05